467 related articles for article (PubMed ID: 16400838)
21. Neutralising antibodies against interferon beta in multiple sclerosis.
Giovannoni G; Deisenhammer F
Lancet; 2004 Jan; 363(9403):166-7; author reply 168-9. PubMed ID: 14726177
[No Abstract] [Full Text] [Related]
22. Summary: Registry data.
Bates D
Neurology; 2011 Jan; 76(1 Suppl 1):S39-41. PubMed ID: 21205682
[No Abstract] [Full Text] [Related]
23. Translating new insights into treatment optimisation in multiple sclerosis.
Fazekas F; Kieseier BC
J Neurol Sci; 2009 Feb; 277 Suppl 1():S1-2. PubMed ID: 19200857
[No Abstract] [Full Text] [Related]
24. Interferon-beta1a treatment for multiple sclerosis.
Sandberg-Wollheim M
Expert Rev Neurother; 2005 Jan; 5(1):25-34. PubMed ID: 15853471
[TBL] [Abstract][Full Text] [Related]
25. Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosis.
Koch M; Mostert J; De Keyser J; Tremlett H; Filippini G
Ann Neurol; 2008 Jan; 63(1):125-6; author reply 126-7. PubMed ID: 17702024
[No Abstract] [Full Text] [Related]
26. Glatiramer and suspected multiple sclerosis. No proven advantage.
Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20941852
[No Abstract] [Full Text] [Related]
27. [Pharmacological treatment of multiple sclerosis].
Myhr KM
Tidsskr Nor Laegeforen; 2010 Mar; 130(5):490-2. PubMed ID: 20224616
[TBL] [Abstract][Full Text] [Related]
28. Neutralizing anti-IFN-beta antibodies: how much more evidence do we need to use them in practice?
Giovannoni G; Goodman A
Neurology; 2005 Jul; 65(1):6-8. PubMed ID: 16009876
[No Abstract] [Full Text] [Related]
29. Interferon beta-1b (Extavia) for multiple sclerosis.
Med Lett Drugs Ther; 2010 Nov; 52(1350):86-7. PubMed ID: 21045760
[No Abstract] [Full Text] [Related]
30. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
Schwid SR; Panitch HS
Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
[TBL] [Abstract][Full Text] [Related]
31. Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies.
Kieseier BC; Hartung HP
Exp Neurol; 2007 Jan; 203(1):1-4. PubMed ID: 17069803
[No Abstract] [Full Text] [Related]
32. Once weekly interferon beta for multiple sclerosis is superseded by higher and more frequent dosing.
Blumhardt LD
Int J Clin Pract Suppl; 2002 Sep; (131):9-16. PubMed ID: 12564807
[TBL] [Abstract][Full Text] [Related]
33. Neutralising antibodies against interferon beta in multiple sclerosis.
Mikol D
Lancet; 2004 Jan; 363(9403):167-8; author reply 168-9. PubMed ID: 14726179
[No Abstract] [Full Text] [Related]
34. Interferon beta babies.
Waubant E; Sadovnick AD
Neurology; 2005 Sep; 65(6):788-9. PubMed ID: 16186513
[No Abstract] [Full Text] [Related]
35. High sensitivity measurement of CRP and disease progression in multiple sclerosis.
Soilu-Hänninen M; Koskinen JO; Laaksonen M; Hänninen A; Lilius EM; Waris M
Neurology; 2005 Jul; 65(1):153-5. PubMed ID: 16009907
[TBL] [Abstract][Full Text] [Related]
36. Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a.
Pakdaman H; Fallah A; Sahraian MA; Pakdaman R; Meysamie A
Neuropediatrics; 2006 Aug; 37(4):257-60. PubMed ID: 17177154
[TBL] [Abstract][Full Text] [Related]
37. Interferon beta-1a treatment and African Americans.
Cantor FK
Arch Neurol; 2006 Apr; 63(4):627-8; author reply 628. PubMed ID: 16606785
[No Abstract] [Full Text] [Related]
38. Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a.
Schwid SR; Decker MD; Lopez-Bresnahan M;
Neurology; 2005 Dec; 65(12):1964-6. PubMed ID: 16380621
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic management of multiple sclerosis.
Blasier MG
Urol Nurs; 2008 Jun; 28(3):217-9. PubMed ID: 18605517
[No Abstract] [Full Text] [Related]
40. Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy.
Pulicken M; Koteish A; DeBusk K; Calabresi PA
Neurology; 2006 Jun; 66(12):1954-5. PubMed ID: 16801674
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
